CORT Earnings

Quarterly EPS
$0.45
Q3 2024
$0.29
Q4 2024
$0.19
Q1 2025
$0.33
Q2 2025
$0.19
Q3 2025
$0.23
Q4 2025
$-0.30
Q1 2026
$0.40
Q2 2026
Latest Revenue256.1M
Latest Net Income43.0M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$0.40256.1M43.0M+31.7%+21.2%
Q1 2026-$0.30164.9M-31761000+4.9%-257.9%
Q4 2025$0.23202.1M24.3M+11.1%-20.7%
Q3 2025$0.19207.6M19.7M+13.7%-57.8%
Q2 2025$0.33194.4M35.1M+18.7%-2.9%
Q1 2025$0.19157.2M20.5M+7.1%-29.6%
Q4 2024$0.29181.9M30.7M+34.3%-3.3%
Q3 2024$0.45182.5M47.2M+47.7%+45.2%
Q2 2024$0.34163.8M35.5M
Q1 2024$0.27146.8M27.8M
Q4 2023$0.30135.4M31.4M
Q3 2023$0.31123.6M31.4M
Corcept Therapeutics (CORT) — Earnings